Subscribe to RSS
DOI: 10.1055/s-0028-1109287
© Georg Thieme Verlag KG Stuttgart · New York
Aktueller Stand der Entwicklung und Anwendung von Farb- und Markierungsstoffen für die vitreoretinale Chirurgie
Present State of the Development and Clinical Use of Dyes and Staining Substances for Vitreoretinal SurgeryPublication History
Eingegangen: 26.9.2008
Angenommen: 13.11.2008
Publication Date:
21 April 2009 (online)
Zusammenfassung
Die Markierung von Gewebestrukturen im hinteren Augensegment hat sich in den vergangenen 8 Jahren zu einem etablierten Bestandteil der vitreoretinalen Chirurgie entwickelt. In dieser Zusammenfassung wird ein Überblick über derzeitig verfügbare Markierungs- und Farbstoffe sowie deren operative Anwendung vermittelt.
Abstract
Staining of intraocular tissue has become an established tool of vitreoretinal procedures within the last 8 years. This review describes the presently available dyes and markers and their use during vitreoretinal procedures.
Schlüsselwörter
Vitalfarbstoffe - Brilliant Blue G - Indocyaningrün - Trypan Blau - Patent Blau - Retina - Vitrektomie - Lamina limitans interna
Key words
vital dyes - brilliant blue G - indocyanin green - trypan blue - patent blue - retina - vitrectomy - internal limiting membrane
Literatur
- 1 Abrams G W, Topping T, Machemer R. An improved method for practice vitrectomy. Arch Ophthalmol. 1978; 96 521-525
- 2 Ando F, Sasano K, Ohba N. et al . Anatomic and visual outcomes after indocyanine green-assisted peeling of the internal limiting membrane in idiopathic macula hole surgery. Am J Ophthalmol. 2004; 137 744-746
- 3 Burk S E, da Mata A P, Snyder M E. et al . Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology. 2000; 107 2010-2014
- 4 Burk S E, Da Mata A P, Snyder M E. et al . Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg. 2003; 29 645-651
- 5 Cevera E, Diaz Llopis M, Salom D. et al . Internal limiting membrane staining using intravitreal brilliant blue G: good help for vitreo-retinal surgeon in training. Arch Soc Esp Oftalmol. 2007; 82 71-72
- 6 Doi N, Uemura A, Nakao K. et al . Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina. 2005; 25 742-745
- 7 Enaida H, Hiatomi T, Goto Y. et al . Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina. 2006; 26 623-630
- 8 Enaida H, Hisatomi T, Hata Y. et al . Brilliant Blue G selectively stains the internal limiting membrane/Brilliant Blue G-assisted membrane peeling. Retina. 2006; 26 631-636
- 9 Engel E, Schraml R, Maisch T. et al . Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci. 2008; 49 1777-1783
- 10 Gandorfer A, Haritoglou C, Gass C A. et al . Indocyanin green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001; 132 431-433
- 11 Gass C A, Haritoglou C, Schaumberger M. et al . Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2003; 24 716-720
- 12 Guo S, Tuela A C, Wagner R. et al . A comparison of the effectiveness of four biostains in enhancing visualization of the vitreous. J Pediatr Ophthalmol Strabismus. 2006; 43 281-284
- 13 Haritoglu C, Gandorfer A, Gass C A. et al . The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthamol. 2003; 135 328-337
- 14 Haritoglu C, Yu A, Freyer W. et al . An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci. 2005; 46 3315-3322
- 15 Haritoglu C, Tadayoni R, May C A. et al . Short-term in vivo evaluation of novel vital dys for intraocular surgery. Retina. 2006; 26 673-678
- 16 Haritoglu C, Schumann R G, Strauss R. et al . Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans. Br J Ophthalmol. 2007; 91 1125-1128
- 17 Hasler P W, Prünte C. Early foveal recovery after macular hole surgery. Br J Ophthalmol. 2008; 92 645-649
- 18 Hata Y, Enaida H, Sassa Y. et al . Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2007; 245 1019-1025
- 19 Hiebl W, Günther B, Meinert H. Substanzen zur Anfärbung von biologischem Gewebe – Farbstoffe in der Augenheilkunde. Klin Mbl Augenheilkd. 2005; 222 309-311
- 20 Hillenkamp J, Saikia P, Herrmann W A. et al . Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007; 245 973-979
- 21 Iriyama A, Uchida S, Yanagi Y. et al . Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004; 45 943-947
- 22 Jackson T L, Hillenkamp J, Knight B C. et al . Safety testing of indocyanin green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci. 2004; 45 2778-2785
- 23 Jackson T L, Griffin L, Vote B. et al . An experimental method for testing novel retinal vital stains. Exp Eye Res. 2005; 81 446-454
- 24 Jin Y, Uchida S, Yanagi Y. et al . Neurotoxic effects of trypan blue on rat retinal ganglion cells. Exp Eye Res. 2005; 81 395-400
- 25 Jonas J B, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exsudative, and neovascular diseases. Prog Retina Eye Res. 2005; 24 587-611
- 26 Kunikata H, Abe T, Sagara Y. et al . Hypthermia of 8 °C protects cultured retinal pigment epithelial cells and retinal ganglion cells against trypan blue toxcicity. Am J Ophthalmol. 2006; 141 754-756
- 27 Lochhead J, Jones E, Chui D. et al . Outcome of ICG-assisted ILM peel in macular hole surgery. Eye. 2004; 18 804-808
- 28 Lüke C, Lüke M, Dietlein T S. et al . Retinal tolerance to dyes. Br J Ophthalmol. 2005; 89 1188-1191
- 29 Lüke C, Lüke M, Sickel W. et al . Effects of patent blue on human retinal function. Graefe’s Arch Clin Exp Ophthalmol. 2006; 244 1188-1190
- 30 Maia M, Haller J A, Pieramici D J. et al . Retinal pigment epithelium abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina. 2004; 24 157-160
- 31 Maia M, Lenner L, deJuan E. et al . Effects of indocyanin green delivery over the retinal surface and into the subretinal space in rabbits. Retina. 2004a; 24 80-91
- 32 Maia M, Margalit E, So M OM. et al . Effects of intravitreal indocyanin green injection in rabbits. Retina. 2004b; 24 69-79
- 33 Maia M, Penha F, Rodrigues E B. et al . Effects of subretinal injection of patent blue and trypan blue in rabbits. Curr Eye Res. 2007; 32 309-317
- 34 Mennel S, Meyer C H, Tietjen A. et al . Patent blue: a novel vital dye in vitreoretinal surgery. Ophthalmologica. 2006; 220 190-193
- 35 Mennel S, Thumann G, Peter S. et al . Einfluss von Vitalfarbstoffen auf die Funktion der äußeren Blut-Retina-Schranke in vitro. Klin Mbl Augenheilkd. 2006a; 223 568-576
- 36 Morrison V L, Koh H J, Cheng L. et al . Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina. 2006; 26 339-344
- 37 Narayanan R, Kenney M C, Kamjoo S. et al . Trypan Blue: Effect of retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci. 2005; 46 304-309
- 38 Penha F, Maia M, Farah M E. et al . Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology. 2007; 114 899-908
- 39 Rodrigues E B, Meyer C H, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2005; 243 291-293
- 40 Rodrigues E B, Meyer C H. Meta-analysis of chromovitrectomy with indocyanin green in macular hole surgery. Ophthalmologica. 2008; 222 123-129
- 41 Ruiz-Moreno J M, Montero J A, Bayon A. et al . Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res. 2007; 84 342-348
- 42 Schuettauf F, Haritoglou C, May C A. et al . Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci. 2006; 47 3573-3578
- 43 Schumann R G, Remy M, Grueterich M. et al . How it appears: electron microscopic evaluation of internal limiting membrane specimens obtained during brilliant blue G assisted macular hole surgery. Br J Ophthalmol. 2008; 92 330-331
- 44 Shah G K, Rosenblatt B J, Blinder K J. et al . Triamcinolone-assisted internal limiting membrane peeling. Retina. 2005; 25 972-975
- 45 Sheidow T G, Blinder K J, Holekamp N. et al . Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology. 2003; 110 1697-1701
- 46 Slaughter K, Lee I L. Macular hole surgery with and without indocyanin green assistance. Eye. 2004; 8 376-278
- 47 Teba F A, Mohr A, Eckhardt C. et al . Trypan blue staining in vitreoretinal surgery. Ophthalmology. 2003; 110 2409-2412
- 48 Ueno A, Hisatomi T, Enaida H. et al . Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina. 2007; 27 499-504
- 49 Uno F, Malerbi F, Maia M. et al . Subretinal trypan blue migration during epiretinal membrane peeling. Retina. 2006; 26 237-239
- 50 Veckenmeer M, Overdam van K, Monzer J. et al . Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2001; 239 698-704
- 51 Vote B J, Russel M K, Joondeph B C. Trypan blue-assisted vitrectomy. Retina. 2004; 24 736-738
Prof. Dr. Heinrich Gerding, FEBO
Abteilung für Retinologie, Klinik Pallas
Louis-Giroud-Str. 20
4600 Olten
Schweiz